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FIGOAbstract Aim: To determine whether the apparent diffusion coefﬁcient (ADC) measurements cal-
culated values were signiﬁcantly different between cervical tumors with different histological char-
acteristics (type, degree of differentiation, and stage of malignancy).
Patients and methods: MRI and DWI scans performed in 26 pathologically proved cancer cervix
patients. ADC values of different pathological types of cervical cancer were compared. Student’s
t test was used for statistical analysis.
Results: There were 18 squamous cell carcinoma and 8 adenocarcinomas showed with biopsy
results. Early stage (FIGO-Ib–IIa, n= 7), (FIGO-IIb–IIIb–IVa, n= 19). The mean ADC values
for squamous cell carcinoma (n= 18), and adenocarcinoma (n= 8) were 0.88 · 103, and
0.91 · 103 mm2/s, respectively. Statistical analysis showed signiﬁcant difference in ADC value
between both tumor types (P< 0.05). There was also signiﬁcant difference between the mean
ADC values of the tumor grade I and the other grades (II, III) (p< 0.05). The mean ADC values
in early stage cervical cancer (0.83 ± 0.05 · 103 mm2/s) were signiﬁcantly lower than the mean
ADC values in late stage disease (0.98 ± 0.06 · 103 mm2/s) (p< 0.05).
Conclusion: ADC value measurements can provide useful information in diagnosis of cervical
cancer as well as in preoperative assessment of the tumor stage.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Uterine cervical cancer is the third most common malignancy
affecting the female genital tract in middle age group
between 45 and 55 years (1,2). Its incidence is increasing
rapidly in developing countries. The International Federation
Table 1 FIGO staging for carcinoma of cervix (3). International Federation of Gynecology and Obstetrics (FIGO) Staging Systems.
 Stage 0: Cervical intraepithelial neoplasia (CIN III)
 Stage I Conﬁned to cervix
Stage Ia Invasive carcinoma only diagnosed by microscopy
Ia1: Stromal invasion <3 mm in depth and <7 mm in extension
Ia2: Stromal invasion >3 mm depth and not >5 mm and extension >7 mm
Stage Ib: Clinically visible lesions limited to the cervix or pre-clinical cancers >stage 1a
Ib1: Clinically visible tumor >4 cm in greatest dimension
Ib2: Clinically visible tumor >4 cm in greatest dimension
 Stage II: Beyond cervix though not to the pelvic sidewall or lower third of the vagina
Stage IIa: Involves upper 2/3rd of vagina without parametrial invasion
Stage IIa1: Clinically visible tumor >4 cm in greatest dimension
Stage IIa2: Clinically visible tumor >4 cm in greatest dimension
Stage IIb: With parametrial invasion
 Stage III
Stage IIIa: Tumor involves the lower third of the vagina with no extension to pelvic sidewall
Stage IIIb: Extension to pelvic side wall or causing obstructive uropathy
 Stage IV: Extension beyond pelvis or biopsy proven to involve the mucosa of the bladder or the rectum
Stage IVa: Extension beyond pelvis or rectal/bladder invasion
Stage IVb: Distant organ spread
Fig. 1 Staging of uterine cervix carcinoma according to FIGO (4).
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Table 3 Comparison between the histopathologic subtypes,
tumor stage, tumor grades and the mean ADC values.
No (%) Mean ADC value
Histopathology
Squamous cell cancer 18 (69.2%) 0.88 · 103 mm2/s*
Adenocarcinoma 8 (30.7%) 0.91 · 103 mm2/s
Tumor stage
Early stage (stages Ib–IIa) 7 (26.9%) 0.83 · 103 mm2/s*
Late stage (stages II–III–IV) 19 (73%) 0.98 · 103 mm2/s
Tumor grade
Grade I 11 (42.3%) 0.90 · 103 mm2/s*
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in 2009 (Table 1 and Fig. 1) is commonly used for treatment
planning but is inadequate in the evaluation of prognostic fac-
tors such as tumor volume and nodal status (3,4). Among the
imaging modalities used in the preoperative evaluation of
cervical cancer, MRI is an excellent modality for depicting
invasive cervical cancer: it can provide objective measurement
of tumor size and provides a high negative predictive value for
parametrial invasion and stage IVa disease (5). Diffusion
weighted imaging (DWI) is a recent approach for evaluating
malignancies. Although it is widely used in the detection and
evaluation of acute stroke (6), with improving MRI technol-
ogy that has reduced the artifacts interfering with the image
interpretation, DWI has been used in body imaging (7,8).
Apparent diffusion coefﬁcient (ADC) maps are calculated
from DWI images and it has been reported that quantitative
evaluation of ADC values might be used for differentiating
benign from malignant tissue (9). Lymph node involvement
is not incorporated in the FIGO staging system, however, it
is an important factor in the choice of adjuvant radiation ther-
apy in cervical cancer. Surgical lymph node assessment is the
gold standard for the diagnosis of lymph node metastases,
accurate preoperative assessment of lymph node metastases
is still very important in patients with cervical cancer from a
clinical point of view. Many studies showed decreased ADC
value in malignant lymph nodes when compared to benign
lymphadenopathy (10,11).Table 2 The patient age, number of each FIGO stage and
detected pelvic LNs.
Grade II 8 (30%) 0.94 · 103 mm2/s
Grade III 7 (26.9%) 0.97 · 103 mm2/s
Pelvic LN+metastasis
Yes 9 (47.3%) 0.77 · 103 mm2/s*
No 10 (52.6%) 1.70 · 103 mm2/s
* P value shows statistically signiﬁcant (P> 0.05).2. Patients and methods
This study was conducted following ethics approval from the
local institutional review boards and all patients gave informed
consent. From December 2012 to November 2014, we evalu-
ated 26 histopathologically proved cervical cancer patients
with early and late stage locally advanced cancer cervix.
Early stage (FIGO-Ib–IIa, n= 7), (FIGO-IIb–IIIb–IVa,
n= 19), who were consecutively referred to our Radiology
department for preoperative/pretherapy MRI assessment.Characteristic Total n= 26

















a Numbers outside parenthesis are average ± standard deviation.
Numbers in parenthesis are range.
b FIGO= International Federation of Gynecology and Obstet-
rics. Numbers in parenthesis are percentage.2.1. Conventional MRI
Patients were prepared for MRI after 6 h of fasting and 20 mg
hyoscine butylbromide (Buscopan) was given intramuscularly
at the start of each examination to reduce bowel peristalsis.
All examinations were performed on a 1.5-T MRI system
(Achieva, Philips Healthcare, Best, the Netherlands) using a
dedicated torso coil. The standard sequences included high-
resolution sagittal T2-weighted turbo spin-echo (TR/TE =
4000/80 ms, turbo factor = 14, ﬁeld of view = 240 · 240 mm,
matrix size = 400 · 392, slice thickness = 4 mm, intersection
gap = 0 mm), axial T2-weighted turbo spin-echo (TR/TE =
2800/100 ms, turbo factor = 12, ﬁeld of view = 403 ·
300 mm, matrix size = 787 · 600, slice thickness = 4 mm,
intersection gap = 0 mm) and T1-weighted turbo-ﬁeld-echo
contrast-enhanced acquisition (TR/TE = 2.4/1.2 ms, ﬁeld of
view = 350 · 350 mm, matrix size = 212 · 211, slice thick-
ness = 3.0 mm, intravenous bolus injection of 0.1 mmol/kg
body weight gadopentetate dimeglumine at 3.0 ml/s), to allow
accurate evaluation of the parametrium.2.2. DW-MRI
DW-MRI was performed using single-shot spin-echo echopla-
nar imaging, immediately after the axial T2-weighted imaging
and before intravenous contrast injection. It was acquired in
free breathing with background body signal suppression (pre-
saturation inversion recovery fat suppression) using the follow-
ing parameters: TR/TE = 2000/54 ms, ﬁeld of view = 403 ·
300 mm, matrix size = 168 · 124, slice thickness = 4 mm,
intersection gap = 0 mm, parallel imaging with sensitivity
encoding factor of 2, receiver bandwidth = 1382.5 Hz per
pixel. We acquired b values (0, 500 and 1000 s/mm2) in the
axial plane covering 20 slices to include the entire cervical
784 D.I. Hasan et al.cancer, using motion-probing gradients in three orthogonal
axes. We ensured that the ﬁeld of view, slice thickness and
intersection gap were the same as the anatomical axial T2-
weighted imaging to allow image overlay and co-registration.
ADC maps were calculated from DW images that were pre-
viously assessed. In the patient group, ADC measurements
were executed on reconstructed ADC maps with the largest
region of interest (ROI) within the tumor. Equal-sized ROIs
(each 5 mm2) that excluded macroscopic necrotic areas (ﬂuid
signal on T2), large vessels and areas with susceptibility arti-
fact caused by air–water interface. The greatest dimension of
the tumor was measured. ROIs were set up three times and
the average of them was used for each ADC value measure-
ment in the malignant masses and detected pelvic L.Ns
(>10 mm in the longitudinal diameter).
2.3. Statistics
Descriptive statistics were used to describe clinical demograph-
ics using range, means and standard deviation (mean ± SD).
A t-test was used to analyze comparisons and a p value < 0.05
was accepted as statistically different. Comparisons of mean
ADC values between histopathological subtypes, tumor grades
and stages were made. Rare cervical cancer subtypes like
small-cell carcinoma were excluded from the study because
of insufﬁcient numbers. Comparisons of mean ADC valuesFig. 2 37 years old female with cervical carcinoma, FIGO stage Ib2
cervical mass involving the posterior lip of the cervix with clear uppe
denoting the absence of parametrial invasion. (C and D) DWI and A
ADC measures 0.687 · 103 mm2/s. Pathologically proved as moderatbetween enlarged metastatic pelvic L.Ns and nonmetastatic
one.3. Results
Twenty-six patients, their average age 35–71 years old
(mean was 59.7 ± 4.6 years). They were premenopause/post-
menopause (20:6) (Table 2).
Pathological diagnoses: Early stage (FIGO-Ib–IIa, n= 7),
(FIGO-IIb–IIIb–IVa, n= 19). According to the International
Federation of Gynecology and Obstetrics (FIGO), classiﬁca-
tion stages I–IIa are considered early stage and stages IIb or
more are considered late stage (3). Seven patients were in the
early stage with 2 patients in stage Ib and 5 in stage IIa, whereas
19 patients were in the late stage, nine patients in stage IIb, 7
patients in stage IIIb and 3 patients in stage IVa (Table 2).
Enlarged L.Ns found in 19/26 of the patients, nine of them were
malignant, while the other 10 patients were hyperplastic lymph
nodes.
There were squamous cell cancer in 18 (69.2%) patients and
adenocarcinoma in 8 (30.7%) patients, with mean ADC values
of 0.88 · 103 mm2/s and 0.91 · 103 mm2/s, respectively.
Apparent diffusion coefﬁcient value of squamous carcinoma
was statistically signiﬁcant lower than that of adenocarcinoma
(P< 0.05) (Table 3).. (A and B) Axial and sagittal T2WI show well deﬁned isointense
r vagina as well as preserved peripheral hypointense stromal ring
DC maps show restricted diffusion of the cervical mass with low
ely differentiated squamous cell carcinoma grade I.
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(26.9%) were in the early stage with 2 patients in stage Ib
(Fig. 2) and 5 in stage IIa (Fig. 3), whereas 19(73%) patients
were in the late stage, 9 patients in stage IIb (Fig. 4), 7 patients
in stage IIIb (Fig. 5) and 3 patients in stage IVa (Fig. 6).
The mean ADC values in early-stage cervical cancer
(0.83 ± 0.05 · 103 mm2/s) were signiﬁcantly lower than
the mean ADC values in the late stage of the disease
(0.98 ± 0.06 · 103 mm2/s) (p< 0.05).
Comparison of mean ADC values for early and late stage
cervical cancer according to FIGO classiﬁcation (Table 3).
There was a signiﬁcant difference between early and late stage
cervical cancer (p< 0.05).
With regard to tumor grades, there were statistical differ-
ence was found between the mean ADC values, grade I
(n:11), and other grades (grade II n:8 and grade III n:7)
(p< 0.05). The mean ADC value of grade I cases was
0.90 · 103 mm2/s, while in grade II and III the mean ADC
values were 0.94 · 103 mm2/s and 0.97 · 103 mm2/s, respec-
tively. There was no statistically signiﬁcant difference between
grade II and grade III (Table 3, Fig. 7).
In the study group the mean ADC values
(0.77 · 103 mm2/s) for metastatic enlarged L.Ns (Fig. 5E
and G), which were statistically signiﬁcant (p< 0.05) than thatFig. 3 47 years old female patient with cervical carcinoma FIGO stag
mass in the cervix displaying low SI on T1 and intermediate signal inte
endometrial cavity with preserved cervical hypointense stromal rin
of the cervical mass with low ADC measures 0.854 · 103 mm2/s. Path
grade III.of the hyperplastic enlarged L.Ns (1.70 · 103 mm2/s)
(Table 3).4. Discussion
Magnetic Resonance Imaging with high soft-tissue resolution
is the most valuable imaging modality in the assessment of
tumor size, depth of cervical invasion and extent of locore-
gional spread in the treatment planning of cervical cancer
(12,13). DWI which has recently been used in the diagnosis
of malignant lesions, can distinguish the normal uterine cervix
from cervical cancer and benign lymph nodes from malignant
ones (14).
In our study the mean ADC values in squamous carcinoma
were statistically lower than those of adenocarcinoma
(p< 0.05). Similar ﬁndings had reported by Lui et al. (15) in
their studying 42 patient group. The different pathological
characteristics are of these two tumor types. Cell of squamous
carcinoma tends to be more compact and crowded, while ade-
nocarcinoma gives out more tube-like structures which mimic
adeno-tissues. These tube-like structures have a large intercel-
lular space which will lead to higher ADC value. DWI, as a
classiﬁcation methodology applied successfully in gliomase IIa. (A and B) Sagittal T2WI and axial T1WI show well-deﬁned
nsity in T2WI extending to upper third of the vagina as well as the
g. (C and D) DWI and ADC maps show restricted diffusion
ologically proved as squamous cell carcinoma nonkeratinized type
Fig. 4 53 years old with cancer cervix FIGO stage IIb. (A) Axial T2WI shows cervical mass displaying isointense SI with interruption of
the hypointense ring denoting parametrial invasion. (B) Axial T2WI at higher level shows enlarged left deep pelvic LN (arrow). (C and D)
DWI and ADC maps show restricted diffusion with low ADC value measures 0.762 · 103 mm2/s. Pathologically proved as squamous cell
carcinoma grade II.
786 D.I. Hasan et al.(16) could probably also been used in pathological subtype
classiﬁcation of cervical tumor.
On contrary Tuna et al. (17) had reported no signiﬁcant dif-
ference between mean ADC values of squamous cell
cancer and adenocarcinoma (0.95 · 103 mm2/s and
0.91 · 103 mm2/s, respectively) (p> 0.05). They explained
that may be related to the smaller patient group of their study.
Mangal et al. (18) found in their study, preoperative estimation
of histologic type based on the ADC values still seems difﬁcult
because there is a considerable overlap between them.
In the present study, according to the FIGO classiﬁcation
stages: the mean ADC values in early-stage cervical cancer
(0.83 ± 0.05 · 103 mm2/s) were signiﬁcantly lower than the
mean ADC values in the late stage of the disease
(0.98 ± 0.06 · 103 mm2/s) (p< 0.05). Several researches
showed potential clinical value of ADC value in differentiating
FIGO stage or pathological grade. Patrick et al. (19) analyzed
relationship between FIGO stage and ADC value. They found
that ADC was signiﬁcantly lower in FIGO stage T1b/T2a than
that in T2b and T3/T4. This may indicate disease prognosis or
help in treatment planning.
McVeigh et al. (9) reported that mean ADC values of
patients with cervical cancer were lower than normal cervix
ADC values. Also, with regard to FIGO classiﬁcation, meanADC values were found to be lower in stages Ib/IIa than in
stage IIb and stages III/IV, as we found in this study. The sig-
niﬁcant difference between the FIGO stages may be a useful
factor in treatment planning, especially for cases in which
the extent of the disease is undetermined. In a study by
Kuang et al. (20), they concluded that in the evaluation of cer-
vical cancer, the diagnostic accuracy of ADC values for the
distinction of cancerous from normal tissue was high.
In our study the ADC values of cervical cancers of higher
pathological grade showed tendency to decrease compared to
those of lower grade, with signiﬁcant difference between grade
I and other grades (II, III). On the other hand, a negative cor-
relation between tumor grade and mean ADC values was
reported in many studies (15,17). While in Ken’s study, the
ADC values of endometrial cancers of higher pathological
grade showed tendency to decrease compared to those of lower
grade, although estimation of histological grade based on
ADC values seems difﬁcult because of considerable overlap
(21).
A study by Chen et al. (22) reported lower mean ADC val-
ues for cervical cancer than for a normal cervix. Also, they
reported that there was an increase in ADC values after radio-
therapy, which indicated that DWI might be used to monitor
the response to therapy. Moreover in patients with cervical
Fig. 5 73 years old patient presented by postmenopausal bleeding with cancer cervix FIGO stage IIIb. (A and B) Sagittal and axial
T2WIs show the large cervical mass involving both anterior and posterior cervical wall distending the cervical canal and extending to the
upper vagina. It displays intermediate SI with interruption of the low-signal-intensity cervical stromal ring. (C) Axial T2-weighted image
on higher level shows bilateral enlarged deep external iliac pelvic LNs. (D and E) DWI shows restricted diffusion in the cervical mass and
L.Ns (arrow). (F and G) Gray ADC map shows low ADC value of the cervical mass and within the enlarged L.N, which were
0.866 · 103 mm2/s and 0.733 · 103 mm2/s respectively. Pathologically proved as invasive well poor differentiated squamous cell
carcinoma grade III.
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Fig. 6 60 years old female presented by postmenopausal bleeding with cancer cervix FIGO stage IVa. (A) Sagittal T2WI Large ill
deﬁned cervical mass involving both anterior and posterior cervical lips, displaying intermediate SI on T2WI, following contrast it shows
homogenous enhancement. Interruption of the T2 hypointense ring. Invasion of the upper 2/3 as well as lower 1/3 of the vagina. (B and C)
DWI at the cervical region and more higher level shows invasion of the posterior UB wall, right pelvic side and enlarged right deep pelvic
LN. (D)Restricted diffusion with ADC value 0.877 · 103 mm2/s. Pathologically proved as of squamous cell carcinoma grade III.
Fig. 7 Box-whisker plots for the mean ADC values of the
histological grades of uterine cervical cancer. The ADC values of
uterine cervical cancer grade I were signiﬁcantly lower than those
of grades II and III.
788 D.I. Hasan et al.cancer, the measurement of ADC values could be an important
factor for assessing response to chemoradiotherapy (23,24).
Within the pelvis, cervical cancer spreads ﬁrst to the
parametrial nodes, then to the obturator and iliac nodes.Although not incorporated in the FIGO staging system, the
presence of lymph node metastases has signiﬁcant prognostic
and treatment consequences. The 5 year survival for node-
positive patients is 39–54%, compared with 67–92% in
patients without nodal involvement (25).
Among our studying group, the mean ADC of metastatic
lymph nodes was signiﬁcantly lower than in benign lymph
nodes, which were 0.77 · 103 mm2/s for metastatic enlarged
L.Ns compared to 1.70 · 103 mm2/s for enlarged hyperplastic
L.Ns. Similar results had reported by Lei et al. (11) and Nakai
et al. (26). Moreover, use of DWI in conjunction with T2-
weighted images identiﬁed 85% of metastatic nodes, while only
25% were identiﬁed on the T2-weighted images alone (26).
DWI sequence increased the sensitivity for identifying lymph
nodes, meaning the information could be used as a map to
aid surgical planning, avoiding extensive lymphadenectomy
and reﬁning radiotherapy ﬁelds (11).
The limitation of our study was that it did not encompass
all of the cervical cancer subtypes.
5. Conclusion
Use of ADC value measurements may provide convenient data
for the diagnosis of cervical cancer as well as for preoperative
assessment of the tumor and nodal staging.
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